Used primarily in pharmaceutical research, 2-Amino-N-ethylnicotinamide serves as a key intermediate in the synthesis of various bioactive compounds. It plays a significant role in developing drugs targeting neurological disorders due to its structural similarity to nicotinamide, a precursor to NAD+. Additionally, it is utilized in the study of metabolic pathways and enzyme interactions, aiding in the discovery of treatments for metabolic diseases. Its application extends to the field of organic synthesis, where it is employed to create complex molecules with potential therapeutic properties.